Radiation and Your Patient

Toxicity Similar, But Overall Survival Poor in Cetuximab vs Cisplatin for HPV-Positive Oropharyngeal Cancer

Toxicity Similar, But Overall Survival Poor in Cetuximab vs Cisplatin for HPV-Positive Oropharyngeal Cancer

In a randomized phase 3 trial, researchers sought to determine if cetuximab-based chemoradiotherapy could be a less-toxic alternative to cisplatin-based chemoradiotherapy in patients with HPV-positive oropharyngeal cancer.

Adjuvant Radiation Therapy Improved Outcomes for Some With Advanced Head and Neck CSCC

Adjuvant Radiation Therapy Improved Outcomes for Some With Advanced Head and Neck CSCC

Researchers determined the 5-year overall and disease-free survival for patients with CSCC of the head and neck who received adjuvant radiation therapy.

Fertility Preservation Comes to the Forefront of Radiation Therapy

Fertility Preservation Comes to the Forefront of Radiation Therapy

Younger age at diagnosis and delayed childbearing are reprioritizing fertility-preserving treatment options.

Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?

Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?

In a 2-pronged study, researchers determined that antiperspirant/deodorant use is a significant part of quality of life for patients with breast cancer, and the practice does not increase risk of skin reactions in the axilla.

Postoperative Radiotherapy Favorable as Adjuvant Treatment for Thymic Neuroendocrine Tumors

Postoperative Radiotherapy Favorable as Adjuvant Treatment for Thymic Neuroendocrine Tumors

A propensity-score matched analysis was used to determine the effect of surgery and postoperative radiotherapy in patients with TNETs.

Light Use of Topical Skin Treatments Before Radiotherapy Appears Safe

Light Use of Topical Skin Treatments Before Radiotherapy Appears Safe

Radiation dose not impacted with light or moderate use of skin treatments, regardless of beam energy, incidence.

Treatment Strategies and Predicting Prognoses in Elderly Patients With Breast Cancer

Treatment Strategies and Predicting Prognoses in Elderly Patients With Breast Cancer

[Cancer Management and Research] Data from a total of 16,998 patients with breast cancer included in the SEER database were evaluated to determine the prognosis of various treatment options for elderly patients.

Advances in Radiogenomics: A Review

Advances in Radiogenomics: A Review

Researchers are seeking genetic biomarkers that can predict which patients are most likely to suffer radiotoxicities and which can safely undergo intensified radiation treatment regimens.

Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer

Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer

Results of a population-based survey, presented at the 2018 ASCO Quality Care Symposium, revealed patients' perceptions regarding choice of treatment of differentiated thyroid cancer (DTC).

Lobectomy vs SBRT: A Comparison of Prognoses and Survival for Early-Stage NSCLC

Lobectomy vs SBRT: A Comparison of Prognoses and Survival for Early-Stage NSCLC

A comparison study demonstrated the difference in survival rates between lobectomy and SBRT for early-stage non-small cell lung cancer.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs